NZ605982A - Compositions containing flavones and anthelmintics - Google Patents

Compositions containing flavones and anthelmintics

Info

Publication number
NZ605982A
NZ605982A NZ605982A NZ60598211A NZ605982A NZ 605982 A NZ605982 A NZ 605982A NZ 605982 A NZ605982 A NZ 605982A NZ 60598211 A NZ60598211 A NZ 60598211A NZ 605982 A NZ605982 A NZ 605982A
Authority
NZ
New Zealand
Prior art keywords
group
anthelmintics
anthelmintic
composition
disclosed
Prior art date
Application number
NZ605982A
Inventor
Dominique Kerboeuf
Fabrice Guegnard
Original Assignee
Agronomique Inst Nat Rech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agronomique Inst Nat Rech filed Critical Agronomique Inst Nat Rech
Publication of NZ605982A publication Critical patent/NZ605982A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed is a composition comprising a flavone compound of formula I, and an anthelmintic selected from the group comprising: levamisole, macrocyclic lactones selected from the group comprising avermectins or from the group comprising milbemycins, benzimidazole derivatives selected from albendazole, thiabenzole, mebendazole, fenbendazole, oxfendazole, febantal, and oxibendazole, that increases the bioavailable amount of the anthelmintic to treat parasitosis for example nematodes. Also disclosed is the use of the composition for preparing a medicinal product that is able to increase the bioavailability of anthelmintics in nematodes, for the treatment or prevention in a vertebrate of a parasitosis due to a nematode belonging to the Helminths phylum of the Metazoa.
NZ605982A 2010-06-18 2011-06-10 Compositions containing flavones and anthelmintics NZ605982A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1054881A FR2961399A1 (en) 2010-06-18 2010-06-18 COMPOSITIONS BASED ON FLAVONES AND ANTHELMINTHICS
PCT/FR2011/051334 WO2011157936A1 (en) 2010-06-18 2011-06-10 Compositions containing flavones and anthelmintics

Publications (1)

Publication Number Publication Date
NZ605982A true NZ605982A (en) 2015-02-27

Family

ID=42668745

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ605982A NZ605982A (en) 2010-06-18 2011-06-10 Compositions containing flavones and anthelmintics

Country Status (6)

Country Link
EP (1) EP2582370A1 (en)
AU (1) AU2011266864C1 (en)
FR (1) FR2961399A1 (en)
NZ (1) NZ605982A (en)
WO (1) WO2011157936A1 (en)
ZA (1) ZA201209745B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110810415B (en) * 2019-11-29 2021-06-15 北京农学院 Application of kaempferol 3, 4' -diglycoside 7-rhamnoside

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6555523B1 (en) * 1999-07-08 2003-04-29 Patrick T. Prendergast Use of cirsiliol and derivatives to treat infections
WO2002069949A2 (en) * 2001-03-06 2002-09-12 Prendergast Patrick T Combination therapy for reduction of toxycity of chemotherapeutic agents
CA2652617A1 (en) * 2006-05-19 2007-11-29 The Hong Kong Polytechnic University Flavonoid dimers and methods of making and using such
WO2008085995A1 (en) * 2007-01-09 2008-07-17 Merck & Co., Inc. Anthelmintic flavones from struthiola argenta
WO2009018326A2 (en) 2007-07-31 2009-02-05 Limerick Biopharma, Inc. Soluble pyrone analogs methods and compositions

Also Published As

Publication number Publication date
AU2011266864A1 (en) 2013-01-10
EP2582370A1 (en) 2013-04-24
WO2011157936A1 (en) 2011-12-22
FR2961399A1 (en) 2011-12-23
ZA201209745B (en) 2014-03-26
AU2011266864C1 (en) 2016-06-02
AU2011266864B2 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
EA201390198A1 (en) Heterocyclic Compound
CY1118048T1 (en) Anti-viral compounds
CO6470845A2 (en) NEW PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND ADDITIONAL DISEASES
BR112012017442A2 (en) substituted bicyclic triazole derivatives as gamma secretase modulators
CY1116328T1 (en) Derivative 4 - aminopyrimidine and their use as adenosine A2A receptor antagonists
AR047993A1 (en) PHARMACEUTICAL COMPOSITION THAT PIMOBENDAN INCLUDES
BR112012000763B8 (en) pyridin-4-yl derivative compounds, pharmaceutical composition, and uses of a compound
SV2009003236A (en) REPLACED DIHYDROPIRAZOLONES FOR THE TREATMENT OF CARDIOVASCULAR AND HEMATOLOGICAL DISEASES
MX2011009847A (en) Anthelmintic agents and their use.
MY152710A (en) Oral compositions containing extracts of garcinia mangostana l. and related methods
CO6640327A2 (en) Pyrazole compounds as sigma receptor inhibitors
UY28726A1 (en) N-CYCLHEXILIMIDAZOLINONAS SUBSTITUTES.PROCEDIMIENTOS FOR ITS PREPARATION AND ITS USE AS MEDICATIONS.
NZ600845A (en) Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles
MX2013003635A (en) N-heteroaryl compounds.
TN2009000275A1 (en) Use of substituted pyranone acid derivatives for the treatment of metabolic syndrome
BR112012013487A2 (en) AMANTADINE COMPOSITIONS AND METHODS OF USE
BR112012023407A2 (en) pharmaceutical powder composition for installation, and process for preparing it.
CU20130063A7 (en) PRODUCTION PROCESS OF CYCLIC DEPSIPEPTIDES
UA103500C2 (en) Sulfoximine-substituted anilinopyrimidine derivatives as cdk-inhibitors, preparation thereof and use as medicinal agents
MX2009009154A (en) Spiro-pyrano-pyrazole derivatives.
UA107183C2 (en) Phenylamine-isonicotinamide compounds, their applications, pharmaceutical composition containing them, and method of treatment of hyperproliferative
CU20140013A7 (en) CYCLOPROPILAMIDE DERIVATIVES DIRECTED AGAINST H3 HISTAMINE RECEIVER
WO2011006935A3 (en) Tetrazole derivatives
MX2011013869A (en) Anthelmintic agents and their use.
BRPI0822206B8 (en) liquid formulation for deferiprone with a pleasant taste.

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUN 2016 BY AJ PARK

Effective date: 20150624

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 10 JUN 2017 BY AJ PARK

Effective date: 20160513

LAPS Patent lapsed